First-line atezolizumab monotherapy vs. single-agent chemotherapy in patients with advanced or metastatic non-small cell lung cancer who are ineligible for platinum-based therapy: Analysis of the IPSOS Asian subpopulation
Year: 2025
Type: article
Language: en
Topic: Lung Cancer Treatments and Mutations
Authors and affiliations:
raw_author_name: Baohui Han
raw_affiliation_strings: Department of Respiratory, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai 200025, China
raw_author_name: Solange Peters
raw_affiliation_strings: Department of Oncology, Centre Hospitalier Universitaire Vaudois, Lausanne University, Lausanne, Switzerland
raw_author_name: Anh Tuan Le
raw_affiliation_strings: Cho Ray Cancer Center, Cho Ray Hospital, Ho Chi Minh City, Vietnam
raw_author_name: Dingzhi Huang
raw_affiliation_strings: Department of Pulmonary Medical Oncology, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, China
raw_author_name: Gang Wu
raw_affiliation_strings: Cancer Center, Union Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan, Hubei 430022, China
raw_author_name: Lejie Cao
raw_affiliation_strings: Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of University of Science and Technology of China, Anhui Provincial Hospital, Hefei 230001, China
raw_author_name: Cam Phuong Pham
raw_affiliation_strings: The Nuclear Medicine and Oncology Center, Bach Mai Hospital, Hanoi, Vietnam
raw_author_name: Jun Zhao
raw_affiliation_strings: Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department I of Thoracic Oncology, Peking University Cancer Hospital & Institute, Beijing 100142, China
raw_author_name: Kai Wang
raw_affiliation_strings: Department of Respiratory and Critical Care Medicine, Center for Oncology Medicine, The Fourth Affiliated Hospital of School of Medicine, and International School of Medicine, International Institutes of Medicine, Zhejiang University, Yiwu, Zhejiang 322000, China
raw_author_name: Nong Yang
raw_affiliation_strings: Cancer Centre, Second People’s Hospital of Hunan Province, Changsha, Hunan 410007, China
raw_author_name: Hua Zhong
raw_affiliation_strings: Department of Respiratory, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai 200025, China
raw_author_name: Youyou Hu
raw_affiliation_strings: F. Hoffmann-La Roche Ltd., Basel, Switzerland
raw_author_name: Stefanie Morris
raw_affiliation_strings: F. Hoffmann-La Roche Ltd., Basel, Switzerland
raw_author_name: Verena Lam
raw_affiliation_strings: Genentech Inc., San Francisco, CA, USA
raw_author_name: Vilma Graupner
raw_affiliation_strings: F. Hoffmann-La Roche Ltd., Basel, Switzerland
raw_author_name: Barbara Gitlitz
raw_affiliation_strings: Genentech Inc., San Francisco, CA, USA
raw_author_name: Elen Hoglander
raw_affiliation_strings: F. Hoffmann-La Roche Ltd., Basel, Switzerland
raw_author_name: Christian Schulz
raw_affiliation_strings: Department of Internal Medicine II, University Hospital Regensburg, Regensburg, Germany
raw_author_name: Siow Ming Lee
raw_affiliation_strings: Department of Oncology, University College London Hospitals NHS Foundation Trust and CRUK Lung Cancer Centre of Excellence, London NW1 2PG, UK